| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +4.35M | 100% | $8.74 | +$38M |
| Sells | 0 | ||||
| Net | +4 | +4.35M | 100% | +$38M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James E. Flynn | Director, * Director by Deputization, 10%+ Owner | $186M | +$37.5M | +25.3% | May 29, 2024 |
| Deerfield Partners, L.P. | Director, Dir. by Deputization/10% Group, 10%+ Owner | $10.4M | Sep 16, 2022 | ||
| Thomas Edward Hamilton | Director | $6.33M | +$500K | +8.58% | Feb 16, 2024 |
| Maimon Carole Ben | President and CEO, Director | $1.24M | Jan 17, 2024 | ||
| Michael Celano | Chief Financial Officer | $537K | Jan 17, 2024 | ||
| Gopi Shankar | Chief Development Officer | $103K | +$18.7K | +22.2% | Jan 17, 2024 |
| Russell Clayton | Chief Medical Officer | $84K | Jan 17, 2024 | ||
| Frank E. Thomas | Director | $22K | +$22K | May 29, 2024 | |
| Thomas O. Daniel | Director | May 12, 2021 | |||
| Jonathan Leff | Director | May 29, 2024 | |||
| Jeffrey W. Sherman | Director | May 29, 2024 | |||
| Joseph Truitt | Director | May 29, 2024 | |||
| Peter Barrett | Director | May 10, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|